GlassScriptPhysician profile
Julio C Echegoyen
NPI 1770801540
$71,138.51
in general payments reported to CMS, 2019-2025
33 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,620 · 2020: $1,939 · 2021: $15K · 2022: $6,527 · 2023: $12K · 2024: $19K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,220 · Honoraria: $858 · Travel and Lodging: $40.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,000.00 |
| Food and Beverage | $16,065.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,220.00 |
| Honoraria | $858.09 |
| Travel and Lodging | $40.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $27,289.25 | 2021-2025 | Centurion, Unity, Lensx |
| Alcon Vision LLC | $20,003.57 | 2019-2025 | Clareon, Lensx, Centurion |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,531.34 | 2019-2021 | |
| Ocular Therapeutix, INC. | $4,012.68 | 2020-2025 | Dextenza |
| Rxsight INC | $2,936.52 | 2020-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Sight Sciences, INC. | $2,802.06 | 2020-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $2,341.45 | 2019-2025 | Idosetr, Istent Infinite, Kxl System |
| Ivantis, INC | $1,337.15 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $945.18 | 2022-2025 | Artevo 800, Lumera 700, Quatera 700 |
| Harrow Eye, LLC | $774.83 | 2023-2025 | Vevye, Iheezo, Triesence |
| Biotissue Holdings INC. | $742.24 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $725.82 | 2022-2025 | Envista Mx60 Iol, Miebo, Vyzulta |
| Dompe US, INC. | $390.68 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $362.93 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $309.21 | 2019-2023 | Artevo 800, Lumera 700, Veracity Surgical |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $260.57 | 2019-2025 | Tecnis Iol, Amo Phaco Needle |
| Tarsus Pharmaceuticals, INC. | $236.69 | 2024-2025 | Xdemvy |
| Allergan, INC. | $233.76 | 2019-2022 | |
| Amgen INC. | $145.59 | 2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $97.29 | 2021-2025 | Cequa |
| Carl Zeiss Meditec Cataract Technology INC. | $96.24 | 2023 | |
| Abbvie INC. | $82.73 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $72.39 | 2019-2020 | |
| Shire North American Group INC | $64.65 | 2019 | |
| Staar Surgical Company | $55.77 | 2019 | |
| Kala Pharmaceuticals, INC. | $52.50 | 2019-2021 | |
| Horizon Therapeutics Plc | $47.65 | 2021 | |
| Oyster Point Pharma, INC. | $42.62 | 2022-2023 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $42.02 | 2021-2023 | Acthar |
| Optovue, INC. | $40.00 | 2019 | |
| Thea Pharma INC. | $23.14 | 2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $20.59 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Echegoyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.